Spatial–temporal analysis and spatial drivers of hepatitis-related deaths in 183 countries, 2000–2019

Author:

Li Jie,Xu Zejia,Zhu Hong

Abstract

AbstractHepatitis is the seventh leading cause of mortality worldwide and is the only communicable disease where mortality is increasing, yet the long-term spatial–temporal variation at global scale and its possible causes, i.e., drivers, remain unknown. Firstly, this study employed the measure of spatial autocorrelation, Moran’s I, and the measure of local spatial cluster, Getis-Ord Gi*, to characterize the spatial variation of mortality due to hepatitis in 183 countries globally for years 2000, 2010, 2015 and 2019. Then, a novel spatial statistical method, named the Geographical Detector, was utilized to investigate eight possible influencing factors, i.e., risk factors, of the spatial–temporal variation of mortality due to hepatitis. The results showed significant disparities of hepatitis-related mortality rates among countries. Hot spots, representing locations with higher mortality rates, were consistently observed in Africa, East Asia, and Southeast Asia, while the cold spots, representing locations with lower mortality rates, were predominantly found in Europe and the Americas. Potential spatial drivers of hepatitis mortality, identified by geographical detector, include “health expenditure”, “universal health coverage”, and “per capita income”. However, “hepatitis B immunization” and “total population” were not identified as significant spatial drivers for hepatitis mortality The findings highlighted the critical role of socioeconomic factors in the variations in hepatitis mortality, and pointed out relative importance of increasing health expenditure, per capita income, and improve universal health coverage on alleviating global hepatitis-related mortality.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference51 articles.

1. Sheena, B. S. et al. Global, regional, and national burden of hepatitis B, 1990–2019: A systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol. Hepatol. 7, 796–829. https://doi.org/10.1016/S2468-1253(22)00124-8 (2022).

2. Thomas, D. L. Global elimination of chronic hepatitis. N. Engl. J. Med. 380, 2041–2050. https://doi.org/10.1056/NEJMra1810477 (2019).

3. World Health Organization. "Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016–2021: Actions for impact." https://apps.who.int/iris/bitstream/handle/10665/341412/9789240027077-eng.pdf (2021).

4. Seto, W.-K., Lo, Y.-R., Pawlotsky, J.-M. & Yuen, M.-F. Chronic hepatitis B virus infection. Lancet 392, 2313–2324. https://doi.org/10.1016/S0140-6736(18)31865-8 (2018).

5. World Health Organization. Global Hepatitis Report 2017. https://apps.who.int/iris/bitstream/handle/10665/255016/9789?sequence=1 (2017).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3